SORMANI, MARIA PIA
 Distribuzione geografica
Continente #
NA - Nord America 263
EU - Europa 130
AS - Asia 83
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 2
Totale 484
Nazione #
US - Stati Uniti d'America 257
IT - Italia 64
SG - Singapore 54
SE - Svezia 23
IN - India 14
BG - Bulgaria 9
FI - Finlandia 6
GB - Regno Unito 6
ID - Indonesia 6
CA - Canada 4
CN - Cina 4
DE - Germania 4
RU - Federazione Russa 4
EU - Europa 3
TG - Togo 3
TR - Turchia 3
UA - Ucraina 3
BR - Brasile 2
CZ - Repubblica Ceca 2
FR - Francia 2
BE - Belgio 1
CH - Svizzera 1
GR - Grecia 1
HK - Hong Kong 1
IE - Irlanda 1
JM - Giamaica 1
KZ - Kazakistan 1
LT - Lituania 1
MX - Messico 1
NL - Olanda 1
RO - Romania 1
Totale 484
Città #
Singapore 44
Chandler 38
Santa Clara 36
Fairfield 19
Rome 17
Ashburn 10
Houston 10
San Paolo di Civitate 10
Boston 9
Cambridge 9
Princeton 9
Sofia 9
Wilmington 8
Jakarta 6
San Diego 6
Seattle 6
Helsinki 5
Lawrence 5
Boardman 4
New York 4
Woodbridge 4
Brusciano 3
Castelnuovo Magra 3
Fasano 3
Lomé 3
London 3
Milan 3
Toronto 3
Towson 3
Andover 2
Ann Arbor 2
Camogli 2
Moscow 2
San Gregorio da Sassola 2
Santa Maria La Carita 2
Trento 2
Turin 2
Vicenza 2
Americana 1
Athens 1
Bari 1
Bremen 1
Brussels 1
Cles 1
Des Moines 1
Dublin 1
Falkenstein 1
Falls Church 1
Frankfurt am Main 1
Fremont 1
Hong Kong 1
Kumar 1
Lappeenranta 1
Mexico City 1
Millbury 1
Monmouth Junction 1
Munich 1
Norwalk 1
Ottawa 1
Paris 1
Pathanamthitta 1
Prescot 1
Pune 1
Ridder 1
Romola 1
Siena 1
São Paulo 1
Zurich 1
Totale 340
Nome #
Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial 65
Disease-modifying therapies and coronavirus disease 2019 severity in multiple sclerosis 53
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies 50
An “all-wheel drive” proposal to accelerate clinical research in common and rare neurological diseases 48
Engraftment kinetics and graft failure after single umbilical cord blood transplantation using a myeloablative conditioning regimen 45
Facing the urgency of therapies for progressive MS — a Progressive MS Alliance proposal 41
6 minute walk test in Duchenne MD patients with different mutations: 12 month changes 31
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy 29
Sars-CoV2 infection in pregnant women with multiple sclerosis 28
Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: Who gains from it? 27
The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study 23
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context 20
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis 17
Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (CladStop) 12
Maternal and fetal outcomes in an Italian multicentric cohort of women with multiple sclerosis exposed to dimethyl fumarate during pregnancy 9
The effect of air pollution on COVID‐19 severity in a sample of patients with multiple sclerosis 8
null 8
null 5
null 5
COVID-19 severity in multiple sclerosis 3
null 3
Totale 530
Categoria #
all - tutte 2.948
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.948


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202142 0 0 0 0 0 0 5 12 11 1 3 10
2021/2022100 0 2 8 6 16 5 1 6 6 0 15 35
2022/2023127 17 26 6 15 14 10 2 12 10 0 3 12
2023/2024113 9 13 8 16 15 18 3 7 0 8 8 8
2024/2025148 2 25 12 24 36 49 0 0 0 0 0 0
Totale 530